20-11-2024
Same-stores sales rose 7% at discounter’s international segment
20-11-2024
Nio’s stock drops after quarterly results and revenue outlook disappoint, despite record deliveries.
20-11-2024
It was the third failed trial for the therapy, called dalzanemdor, which also failed to meet its goals in a Phase 2 trial as a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease.
20-11-2024
The drug company had been searching for a new chief scientific officer since July with Mikael Dolsten leaving after 15 years at the company.